Scotiabank downgraded Macerich to Underperform from Sector Perform with a price target of $14, down from $16. The firm cites the company’s “somewhat disappointing” Q1 results and the announcement of its strategic plan to address leverage for the downgrade. Although Scotiabank believes action is needed to address Macerich’s high net debt to EBITDA leverage, it says the path to low-to-mid six-times leverage will result in 3-4 years of earnings headwinds as assets are sold or handed back to lenders. Plus, there is the potential for another round of equity issuance driven shareholder earnings dilution of 10%, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAC:
- CORRECTION – Macerich Announces Initial Progress in its Path Forward Strategic Plan
- UPDATE – Macerich Announces Initial Progress in its Path Forward Strategic Plan
- Macerich Announces Initial Progress in its Path Forward Strategic Plan
- Macerich announces recent purchases in Arizona, Texas
- Fly Insider: Sensata, BioMarin among week’s notable insider trades